DK598688D0 - Oxathiolanderivater - Google Patents

Oxathiolanderivater

Info

Publication number
DK598688D0
DK598688D0 DK598688A DK598688A DK598688D0 DK 598688 D0 DK598688 D0 DK 598688D0 DK 598688 A DK598688 A DK 598688A DK 598688 A DK598688 A DK 598688A DK 598688 D0 DK598688 D0 DK 598688D0
Authority
DK
Denmark
Prior art keywords
hydrogen
group
sec
aminoalkyl
hydroxyalkyl
Prior art date
Application number
DK598688A
Other languages
English (en)
Other versions
DK175064B1 (da
DK598688A (da
Inventor
Abraham Fisher
Ishai Karton
Original Assignee
Israel State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Israel State filed Critical Israel State
Publication of DK598688D0 publication Critical patent/DK598688D0/da
Publication of DK598688A publication Critical patent/DK598688A/da
Application granted granted Critical
Publication of DK175064B1 publication Critical patent/DK175064B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/12Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D497/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK198805986A 1987-10-28 1988-10-27 Spiro-oxathiolan/quinuclidinforbindelser, præparat indeholdende disse og anvendelse af disse til fremstilling af et farmaceutisk præparat DK175064B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11447387A 1987-10-28 1987-10-28
US11447387 1987-10-28
US18921088 1988-05-02
US07/189,210 US4876260A (en) 1987-10-28 1988-05-02 Oxathiolanes

Publications (3)

Publication Number Publication Date
DK598688D0 true DK598688D0 (da) 1988-10-27
DK598688A DK598688A (da) 1989-04-29
DK175064B1 DK175064B1 (da) 2004-05-17

Family

ID=26812231

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198805986A DK175064B1 (da) 1987-10-28 1988-10-27 Spiro-oxathiolan/quinuclidinforbindelser, præparat indeholdende disse og anvendelse af disse til fremstilling af et farmaceutisk præparat

Country Status (13)

Country Link
US (1) US4876260A (da)
EP (1) EP0314444B1 (da)
JP (1) JP2753280B2 (da)
KR (1) KR910007979B1 (da)
AT (1) ATE138663T1 (da)
AU (1) AU608903B2 (da)
CA (1) CA1315791C (da)
DE (1) DE3855325T2 (da)
DK (1) DK175064B1 (da)
ES (1) ES2087854T3 (da)
IL (1) IL87834A (da)
NO (1) NO167806C (da)
NZ (1) NZ226415A (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852029A (en) * 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
JP2683783B2 (ja) * 1992-07-10 1997-12-03 雪印乳業株式会社 シェーグレン症候群治療剤
DE4343838C2 (de) * 1993-12-22 1998-07-09 Lohmann Therapie Syst Lts Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung
US6479074B2 (en) 1996-10-24 2002-11-12 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6572880B2 (en) 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6290986B1 (en) 1996-10-24 2001-09-18 Pharmaceutical Applications Associates, Llc Method and composition for transdermal administration of pharmacologic agents
JP2002500652A (ja) 1997-05-30 2002-01-08 ニューロサーアチ・アクティーゼルスカブ スピロ−キヌクリジン誘導体、その製造方法及びその使用方法
US20040209849A1 (en) * 1998-11-27 2004-10-21 Sanochemia Pharmazeutika Aktiengesellschaft Use of effectors of the central cholinergic nervous system for treatment of delirium
JP4447685B2 (ja) * 1999-01-14 2010-04-07 第一三共株式会社 皮膚乾燥症治療剤
US6433168B1 (en) 1999-07-26 2002-08-13 Sumika Fine Chemicals Co., Ltd. Highly pure phenothiazine compound, production method thereof, production method of intermediate therefor, and hydrate and novel crystal as starting materials for the intermediate
US20040062310A1 (en) 2002-01-17 2004-04-01 Zhong Xue Coding distortion removal method, video encoding method, video decoding method, and apparatus and program for the same
BR0309875A (pt) * 2002-05-03 2007-04-10 Israel Inst For Biolog Res Isr métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
CA2654262A1 (en) * 2006-06-20 2007-12-27 Wyeth Kv1.5 potassium channel inhibitors
US8143400B2 (en) * 2008-01-10 2012-03-27 Apotex Pharmachem Inc. Process for the preparation and purification of cis-2-methylspiro(1,3-oxathiolane-5,3′)quiniclidine hydrochloride
US20110224231A1 (en) * 2008-11-23 2011-09-15 Pfizer Inc. Novel Lactams as Beta Secretase Inhibitors
US9034891B2 (en) 2009-01-26 2015-05-19 Israel Institute For Biological Research Bicyclic heterocyclic spiro compounds
AU2010207486B2 (en) 2009-01-26 2013-03-07 Israel Institute For Biological Research Bicyclic heterocyclic spiro compounds
CN101798311A (zh) * 2010-04-07 2010-08-11 天津炜杰凯华科技有限公司 顺式西维美林的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2146962A1 (en) * 1971-07-28 1973-03-09 Yoshitomi Pharmaceutical Aza-spirodecanones - useful in treating gastric disorders
IL48453A (en) * 1975-11-11 1980-06-30 Purdue Frederick Co Substituted 6-oxa-1-azatricyclo-(6.2.2.0 )dodecan-5-ones and 1,4-ethano-5-oxo octa (or decahydro)quinoline,their preparation and pharmaceutical compositions containing them
IL48452A (en) * 1975-11-11 1979-07-25 Purdue Frederick Co Spiro (1,3-dioxolane-4,3') quinuclidines,their preparationand pharmaceutical compositions comprising them
US4855290A (en) * 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
ZA868369B (en) * 1986-01-10 1987-11-25 Israel State Derivatives of quinuclidine
IL87234A (en) * 1987-08-13 1992-02-16 Israel Inst Biolog Res Optical isomers of 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU2367188A (en) 1989-05-04
IL87834A0 (en) 1989-03-31
DE3855325T2 (de) 1996-10-10
EP0314444A3 (en) 1990-11-07
US4876260A (en) 1989-10-24
DK175064B1 (da) 2004-05-17
NO167806C (no) 1991-12-11
DK598688A (da) 1989-04-29
NO884790D0 (no) 1988-10-27
NO884790L (no) 1989-05-02
NZ226415A (en) 1990-05-28
ES2087854T3 (es) 1996-08-01
NO167806B (no) 1991-09-02
JPH0262883A (ja) 1990-03-02
CA1315791C (en) 1993-04-06
DE3855325D1 (de) 1996-07-04
AU608903B2 (en) 1991-04-18
EP0314444A2 (en) 1989-05-03
JP2753280B2 (ja) 1998-05-18
KR910007979B1 (ko) 1991-10-05
KR890006641A (ko) 1989-06-15
EP0314444B1 (en) 1996-05-29
IL87834A (en) 1992-05-25
ATE138663T1 (de) 1996-06-15

Similar Documents

Publication Publication Date Title
DK598688A (da) Spiro-oxathiolan/quinuclidin
CA2066640A1 (en) Heterocyclic compounds
NZ240676A (en) Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof
DE3470420D1 (en) Novel 1,8-naphthyridine derivatives, and process for preparation thereof
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
ES8601202A1 (es) Procedimiento para la produccion de espirosuccinimidas
JO1077B1 (en) New heterocyclic derivatives of phenoxiamine, methods of preparation and use as a local anesthetic.
DK0573318T3 (da) 4-phenylcarbamoyl-3-isoxazolcarboxylsyreforbindelser, fremgangsmåde til deres fremstilling, farmaceutiske præparater med in
ZA873350B (en) Substituted pyridine herbicides
HU903489D0 (en) Process for producing serotonine-2-receptor antagonistic heterocyclic compounds
HUT75647A (en) Imidazolidinone derivatives and pharmaceutical compositions containing them, which are suitable for treament of senile dementia
PT89098A (pt) Processo para a preparacao de derivados de guanina
NO169391C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt (-)-cis-quinuklidin og syreaddisjonssalter derav
DK423188D0 (da) Svovlforbindelser, fremgangsmaade til deres fremstilling samt laegemidler indeholdende disse forbindelser
ES8305359A1 (es) Un procedimiento para la preparacion de benzamitas sustituidas.
CA1267150C (en) THIABICYCLOHEPTANE SUBSTITUTION DERIVATIVES OF AMINO-PROSTAGLANDIN ANALOGS
NO900234L (no) Cykloheksan-acetamidderivater.
SE8803765D0 (sv) Nya isopolypeptider samt foerfarande foer framstaellning av desamma
NO164901C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetraoxo-3,7-diazabicyclo (3,3,1)-nonanforbindelser.
ES478072A1 (es) Un procedimiento de preparacion de 2-metoxi-benzamidas.
HUT51614A (en) Process for producing cardio-protective and suitable for treating ischemic illnesses pharmaceutical compositions containing nitriferous heterocyclic compounds as active agent as well as for producing the active agents

Legal Events

Date Code Title Description
PUP Patent expired